A summary of second systemic pulmonary shunt for congenital heart disease with pulmonary hypoxemia

Yang XY, Jing XY, Chen Z, Li L, Fan XM, Su JW.Version 2. J Cardiothorac Surg. 2020 May 14;15(1):97. doi: 10.1186/s13019-020-01132-z.PMID: 32410655 Free PMC article.

 

Abstract

Background: There has been an increasing number of children with congenital heart disease that undergo primary or second systemic-pulmonary shunt, while there are few reports on the second systemic-pulmonary shunt. Therefore, this study summarizes the experience of second systemic-pulmonary shunt for congenital heart disease in our hospital.

Methods and results: Sixty-five children with congenital heart disease who underwent systemic-pulmonary shunt for the second time in our hospital were analyzed. At the early stage after the operation, cyanosis improved and SpO2 significantly increased. One patient died in hospital (1.54%) and the causes of death were aggravated atrioventricular regurgitation, low cardiac output syndrome, and liver failure. Early complications occurred in 18 patients (27.7%). All the children were rechecked in our hospital every 3-6 months and the McGoon index significantly increased.

Conclusion: Systemic-pulmonary artery shunt can promote pulmonary vascular development, improve cyanosis symptoms, and increase the chance of radical treatment in children with pulmonary vascular dysplasia.

 

source:https://pubmed.ncbi.nlm.nih.gov/32410655/

0 Comments